Nobel Prize-Winning Chemist Joins Israeli Biopharma Company’s Advisory Board 

Prof. Roger D. Kornberg, the Nobel Prize-winning chemist from Stanford University, is poised to join Rehovot-based Tissue Dynamics’ advisory board, a pioneering biopharma company specializing in artificial intelligence/machine learning (AI/ML). Tissue Dynamics is revolutionizing drug development through its DynamiX platform, employing sensor-embedded human-on-chip models to accelerate R&D, cut costs, and reduce dependence on animal testing. 

The DynamiX platform has already achieved remarkable feats, contributing significantly to a highly effective antiviral therapy’s development which recently concluded successful Phase 3A clinical trials. Additionally, it facilitated preclinical studies for a novel biological therapy targeting fatty liver disease, holding immense promise for medical breakthroughs.